Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.
The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.
2 FluoroPharma directors resign
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.
The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.